Pancreas problems prompt weight loss jab study
A new program has been initiated in the UK to explore reports of serious side effects associated with commonly used weight loss drugs, after numerous individuals reported pancreatic problems. The research, organized by the Medicines and Healthcare products Regulatory Agency (MHRA) together with Genomics England, aims to discover if genetic factors contribute to negative responses to these medications.Injections for weight management, including popular brands like Mounjaro, Ozempic, and Wegovy, have gained traction as aids for tackling obesity and type 2 diabetes. Nonetheless, health authorities are currently investigating incidents of both acute and chronic pancreatitis among consumers. Although a concrete association…
